BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7176188)

  • 1. [Hemodynamic and humoral effects of prazosin in patients with essential hypertension].
    Higa T; Kida O; Morotomi Y; Kodama K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):937-45. PubMed ID: 7176188
    [No Abstract]   [Full Text] [Related]  

  • 2. [The hemodynamic effects of oral prazosine and intravenous nicergoline in heart failure (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Ourbak P; Maurice P
    Ann Cardiol Angeiol (Paris); 1980; 29(5):379-84. PubMed ID: 7425504
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension.
    Letcher RL; Chien S; Laragh JH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S8-20. PubMed ID: 94641
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.
    Mulvihill-Wilson J; Graham RM; Pettinger W; Muckleroy C; Anderson S; Gaffney FA; Blomqvist CG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S1-7. PubMed ID: 94635
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effect of prazosin in congestive cardiac insufficiency of acute degree].
    López-Sendón J; Coma Canella I; Lombera F; Martin Jadraque L
    Rev Esp Cardiol; 1979; 32(3):253-9. PubMed ID: 493628
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 7. Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in man.
    Preston RA; O'Connor DT; Stone RA
    J Cardiovasc Pharmacol; 1979; 1(3):277-86. PubMed ID: 94396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1977 Apr; 4(2):141-5. PubMed ID: 577181
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
    Lund-Johansen P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):107S-111S. PubMed ID: 583322
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effect of prazosin alone and its combination with polythiazide in patients with essential hypertension.
    Guevara J; Collet-Velasco H; Velasco M
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):751-6. PubMed ID: 827421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thermodiagnostic assessment of the trimepranol - prazosin combination in arterial hypertension (author's transl)].
    Kaderávek F
    Cas Lek Cesk; 1981 Jan; 120(2):47-51. PubMed ID: 6110481
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine].
    Ellingsen O; Kjekshus J
    Tidsskr Nor Laegeforen; 1984 Mar; 104(9):657-60. PubMed ID: 6729795
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin in hypertension. Part II. Effects of the initial dose.
    Turner AS; Watson OF; Brocklehurst JE
    N Z Med J; 1977 Sep; 86(596):286-9. PubMed ID: 343006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic changes induced with prazosin in basic conditions and during some pressor tests in essential hypertension].
    Palatini P; Pessina AC; Bozza G; Semplicini A; Veronese P; Ardigò A; Casiglia E; Dal Palù C
    Boll Soc Ital Cardiol; 1978; 23(4):718-25. PubMed ID: 757358
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-invasive hemodynamic study of the acute oral administration of prazosin in stages I and II arterial hypertension].
    Agostini A; Antonini F; Pellegrini F; Rimatori C; Russo P
    Cardiologia; 1983 Jan; 28(1):55-60. PubMed ID: 6686938
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
    Klein W; Goebel R
    Z Kardiol; 1980 Feb; 69(2):120-5. PubMed ID: 6779433
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic changes caused by prazocin in patients with uncomplicated arterial hypertension].
    Ban Hayashi E; Meaney E; Rivera JM
    Arch Inst Cardiol Mex; 1983; 53(4):357-62. PubMed ID: 6639214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.